Clinical Trials
3 trialsNCT02386800 2026-05-27
CINC424A2X01B Rollover Protocol
Novartis
Phase 4 Active not recruiting
NCT03878524 2024-03-04
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
OHSU Knight Cancer Institute
Phase 1 Terminated
NCT01298934 2015-03-06
LBH589 (Panobinostat) for the Treatment of Myelofibrosis
Icahn School of Medicine at Mount Sinai
Phase 1/2 Unknown